No Data
No Data
Edwards Lifesciences Reports Robust Q1 2025 Growth
CCORF Maintains Edwards Lifesciences(EW.US) With Hold Rating, Raises Target Price to $75
A Quick Look at Today's Ratings for Edwards Lifesciences(EW.US), With a Forecast Between $75 to $90
Express News | Canaccord Genuity Maintains Hold on Edwards Lifesciences, Raises Price Target to $75
Cautious Outlook on Edwards Lifesciences Amid Growth Potential and Market Challenges
Hold Rating on Edwards Lifesciences: Balancing Positive Trends With TAVR Uncertainties